Jeffrey A. Meckler, CEO and Director at Indaptus Therapeutics, Inc. (INDP), bought 12,000 shares at $7.00 ($84K) on 2021-09-14, disclosed to the SEC on 2021-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TVTX | SELL | 2024-09-30 | $562K | — | Filing → |
| INDP | BUY | 2022-11-22 | $19K | — | Filing → |
| INDP | BUY | 2022-09-12 | $29K | — | Filing → |